StockWatch
·
BAJAJ CONSUMER CARE · Q2 FY27 · THE VERDICT

Growth Accelerates, But Margins Squeezed—Q3 Pricing Will Decide

Bajaj delivered 25.5% revenue growth and 65.9% PAT expansion, tracking full-year guidance. But sequential revenue fell 2.6%, gross margin compressed despite prior pricing, and management explicitly withheld next-quarter visibility. The market's 9.91% day-1 sell-off reflects the real story: can the company pass through a planned 5% Q3 price increase without demand destruction?

Q2 FY27 resultsBAJAJCONBajaj Consumer Care Ltd21 Oct 2026 · 6 min read
Q2 Revenue

₹333 Cr

+25.5% YoY | -2.6% QoQ

Q2 PAT

₹70 Cr

+65.9% YoY | -0.8% QoQ

Gross margin

59.9%

-180 bps QoQ

EBITDA margin

24.7%

Held via cost control

Bajaj's Q2 headline numbers are strong: revenue grew 25.5% year-on-year and PAT jumped 65.9%, both consistent with the high-teens FY27 guidance management reaffirmed on the call. But the deeper read reveals why management is hedging. Revenue declined 2.6% sequentially, and PAT was essentially flat (down 0.8%) quarter-over-quarter. More telling: gross margin compressed 180 basis points from Q1 to Q2 despite pricing actions already taken in Q1, signaling that input inflation is outpacing pricing realization—at least so far. The company defended EBITDA at 24.7% through cost discipline, but that is a brittle position if Q3's planned 5% price increase doesn't hold with consumers.

The claims check

What management said vs. what the numbers show

H1 FY27 revenue up 28% YoY to ₹674 Cr

Q1 ₹341 Cr + Q2 ₹333 Cr = ₹674 Cr confirmed; growth pace consistent with high-teens FY27 target

Supported

Almond Drops showing double-digit unit volume growth

Stated 10%+ unit growth; 25.5% revenue growth YoY supports strong ADHO contribution as primary driver

Supported

Sequential revenue and momentum steady (implied near-flat QoQ)

Revenue down 2.6% QoQ (₹341 Cr Q1 → ₹333 Cr Q2); PAT down 0.8% QoQ. Both trends are deteriorating

Contradicted

FY27 margin targets and guidance (implicit from prior quarter commentary)

Management declined to quantify FY27 EBITDA or PAT margins; said 'can't give answer' on margin trajectory

Guidance withheld

What changed on this call

Guidance reaffirmed, not raised. Despite 25.5% Q2 growth, management held FY27 expectations at high-teens and explicitly declined to lift targets. This is the call's clearest signal of caution: management sees demand softening or macro headwinds robust enough to warrant a hold-the-line stance rather than confidence-driven uplift. Q3 pricing crystallized. Management outlined a ~5% price increase (2–3% consumer facing + ml-age reduction) for Q3. This is explicit escalation after Q1's calibrated increase. The unproven variable: consumer acceptance. Management cited 'early data optimistic,' but this quarter will be the real test. Aarohan 2.0 distribution scope clarified. Pan-India 10% year-on-year expansion of direct distribution reach, targeting a 75% index (from ~50% now). Concrete and ambitious, but notably, management offered no quantified revenue uplift per outlet added—a point analyst Tejas Shah pressed on directly, and management defended on strategy grounds rather than hard ROI data.

The bull-bear case

The bull-bear ledger
  • FY27 guidance on track: 25.5% Q2 YoY, H1 28% YoY consistent with high-teens full-year

  • Sequential revenue decline -2.6% & PAT -0.8% QoQ despite strong YoY growth

  • Gross margin compression -180 bps QoQ despite Q1 pricing = inflation outpacing realization

  • EBITDA margin held 24.7% through cost control and media optimization

  • Management explicitly withheld next-quarter guidance and margin targets

  • Almond Drops showing 10%+ unit growth; new 360° campaign (TV + digital) launched

  • Q3 5% price increase (2–3% consumer + ml-age) is unproven consumer acceptance test

  • FII ownership declined 48 bps QoQ; stock down 35.4% from ATH of ₹692

Risks, ranked by holder concern

What could derail the strategy, and why it matters

Q3 pricing acceptance fails; consumer demand softens post-hike

High

Gross margin already compressed 180 bps QoQ despite prior pricing in Q1. If Q3's 5% increase is met with volume destruction or demand pullback, management faces a Hobson's choice: withdraw pricing (margin collapse) or accept volume loss (growth miss). Neither scenario sustains current guidance.

Sequential revenue softness continues into H2 FY27

High

Revenue down 2.6% QoQ despite 10%+ unit growth suggests channel mix headwinds or market saturation. If this trend persists after Q3 pricing, the high-teens FY27 growth guidance is at risk. Momentum is the question mark.

Aarohan 2.0 capex not translating to proportionate revenue growth

Medium

Analyst Tejas Shah directly challenged industry-wide evidence that direct distribution expansion drives commensurate revenue lift. Naveen defended Bajaj's strategy (portfolio diversity, pricing power) but offered strategic rationale, not hard ROI proof. If reach gains outpace revenue growth, distribution capex ROI is questioned.

Macro headwinds persist; rural demand softness, El Niño, inflation uncontrolled

Medium

Management flagged rural demand concerns, El Niño impact, and hyperinflationary cost environment. While optimistic on government intervention, these are uncontrolled externalities. Further inflation persistence could force deeper margin pressure or growth miss.

How the street is positioned

The market's reaction to Bajaj's result was blunt: a 9.91% sell-off on day 1 of announcement, with only 38.8% delivery (meaning 61.2% of typical trading volume was unexecuted, a signal of broad institutional unwinding rather than orderly repricing). The selling continued: by October 19, the stock had fallen to ₹447.05, 14% below the announcement-day close and 35.4% below its all-time high of ₹692. The stock now trades below its 20-day, 50-day, and 200-day simple moving averages; RSI sits at 36.8 (neutral, slightly oversold). Ownership data confirms institutional caution: FII holdings declined 48 basis points quarter-on-quarter (from 16.59% in Q4 FY26 to 16.11% in Q1 FY27), signaling foreign institutions are trimming exposure. DII holdings ticked up 64 bps, offering modest offset. The promoter stake remains stable at 42.97%. In plain terms: the market has already repriced Bajaj for substantial execution risk. A 35% drawdown from ATH is heavy, but it reflects the central tension of the call—headline growth that looks credible on guidance but is increasingly dependent on an unproven pricing action. Institutions are taking risk off ahead of Q3.

What to watch next

Three things that will resolve the Q3 debate
  • 1 · Q3 pricing implementation & consumer response

    Does the 5% increase (2–3% consumer + ml-age reduction) hold volume, or does elasticity crack demand? This is the binary bet. Management's 'early data optimistic' is anecdotal. Real evidence comes only when Q3 results land and confirm whether volume growth remained double-digit or turned negative post-pricing.

  • 2 · Almond Drops campaign ROI & momentum durability

    The TV + digital 360° campaign is live now. Will new positioning (hair strength → beauty narrative) drive sustained 10%+ unit growth, or does campaign underperformance or brand fatigue emerge? ADHO is flagged as the primary growth engine for the next 6–8 quarters; this quarter tests whether the reinvigoration thesis is real.

  • 3 · Gross & EBITDA margin stabilization post-pricing

    Does gross margin stabilize at ~60% and EBITDA margin hold ~25% in Q3, or compress further? If pricing traction is genuine, margins should stabilize or inch higher. If they compress again (as they did QoQ in Q2), it signals input inflation is still outpacing realization—evidence the 5% hike was insufficient and structural cost pressure runs deeper than management is publicly admitting.

Bajaj Consumer Care is a well-managed franchise with credible long-term strategy (multi-vector growth, brand reinvigoration, distribution modernization) and a proven track record of guidance execution. Q2 FY27 delivers on that playbook: 25.5% revenue growth, 65.9% PAT expansion, EBITDA margin defended at 24.7%.

But the call revealed a harder truth: input inflation has cornered the company into a pricing position, and pricing power is now the variable that matters most. Sequential revenue decline, gross margin compression despite prior pricing, and management's explicit caution on near-term visibility are signals that demand is softening and the consumer test is real.

At current levels—35% below ATH—the stock has repriced for this risk. It is no longer a safety-margin story. It is a 'show me' story on Q3 pricing acceptance. If the 5% increase holds volume and Q3 margins stabilize, this becomes a screaming buy for holders with a 2–3 quarter conviction horizon. If volume cracks or margins compress again, further downside is likely.

The single number to track: Q3 gross margin and revenue growth post-pricing. A positive revenue growth rate paired with stable or rising EBITDA margin confirms pricing power. Anything less is evidence that structural cost pressure is outrunning the company's ability to pass it through—and the market will reprrice accordingly.

Informational and educational content only. Not investment advice.